medigraphic.com
ISSN 0188-9796 (Print)

2008, Number 1

<< Back Next >>

Rev Endocrinol Nutr 2008; 16 (1)

Genetic sides of the human obesity

Canizales-Quinteros S

Language: Spanish
References: 57
Page: 9-15
PDF size: 108.44 Kb.


ABSTRACT

Obesity is a chronic and multifactorial disease with important social, sanitary and economical consequences, which has become a serious health problem worldwide. The increasing prevalence of obesity in Mexico over the last seven years is alarming, as more than 70% of the adult population is currently overweight or obese. The accumulation of adipose tissue has a genetic basis not only in monogenic forms of obesity, but also in common polygenic obesity and the majority of cases result from the interaction of both genetic and environmental factors. This review describes the main genes associated with human obesity, including the recent identification of genes through genome-wide scans whose role in the etiology of obesity is still under discussion. Recent findings on the genetic basis of obesity in the Mexican population are also discussed. Understanding the genetic and molecular bases that cause susceptibility to develop this disease may lead to more adequate preventive and therapeutic actions applicable in public health programs to decrease the prevalence of obesity.


REFERENCES

  1. Steinberger J, Jacobs DR, Raatz S, Moran A, Hong CP, Sinaiko AR. Comparison of body fatness measurements by BMI and skinfolds vs dual energy X-ray absorptiometry and their relation to cardiovascular risk factors in adolescents. Int J Obes (Lond) 2005; 29: 1346-52.

  2. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a World Health Organization consultation on obesity. WHO: Genova, 1997.

  3. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004; 79: 379-84.

  4. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 311: 158-61.

  5. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-86.

  6. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-43.

  7. Bjorntorp P. The origins and consequences of obesity. Diabetes Ciba Found Symp 1996; 201: 68-80.

  8. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-27.

  9. Yun S, Zhu BP, Black W, Brownson RC. A comparison of national estimates of obesity prevalence from the behavioral risk factor surveillance system and the National Health and Nutrition Examination Survey. Int J Obes (Lond) 2006; 30: 164-70.

  10. ENSANUT. Secretaría de Salud. 2006; México.

  11. Prentice AM, Jebb SA. Obesity in Britain: gluttony or sloth? BMJ 1995; 311: 437-39.

  12. Damcott CM, Sack P, Shuldiner AR. The genetics of obesity. Endocrinol Metab Clin North Am 2003; 32: 761-86.

  13. O’Rahilly S, Farooqi IS, Yeo GS, Challis BG. Minireview: Human obesity-lessons from monogenic disorders. Endocrinology 2003; 144: 3757-64.

  14. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet 2005; 6: 221-34.

  15. Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. JAMA 1986; 256: 51-4.

  16. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N Engl J Med 1990; 322: 1483-87.

  17. Allison DB, Kaprio J, Korkeila M, Koskenvuo M, Neale MC, Hayakawa K. The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Disord 1996; 20: 501-6.

  18. Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet 1962; 14: 353-62.

  19. Friedman JM. A war on obesity, not the obese. Science 2003; 299: 856-58.

  20. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-55.

  21. Voight BF, Kudaravalli S, Wen X, Pritchard JK. A map of recent positive selection in the human genome. PLoS Biol 2006; 4: e72.

  22. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.

  23. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O’Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-8.

  24. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 92: 398-401.

  25. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998; 20: 113-14.

  26. Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O’Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998; 20: 111-12.

  27. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998; 9: 55-7.

  28. Jackson RS, Creemers JW, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, Hutton JC, O’Rahilly S. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997; 16: 303-6.

  29. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, Perusse L, Bouchard C. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006; 14: 529-644.

  30. Butler MG. Prader-Willi syndrome: current understanding of cause and diagnosis. Am J Med Genet 1990; 35: 319-32.

  31. Jiang Y, Tsai TF, Bressler J, Beaudet AL. Imprinting in Angelman and Prader-Willi syndromes. Curr Opin Genet Dev 1998; 8: 334-42.

  32. Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, Nelson-Williams C, Raja KM, Kashgarian M, Shulman GI, Scheinman SJ, Lifton RP. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004; 306: 1190-4.

  33. Farooqi IS, O’Rahilly S. Monogenic obesity in humans. Annu Rev Med 2005; 56: 443-58.

  34. Boutin P, Dina C, Vasseur F, Dubois S, Corset L, Seron K, Bekris L, Cabellon J, Neve B, Vasseur-Delannoy V, Chikri M, Charles MA, Clement K, Lernmark A, Froguel P. GAD2 on chromosome 10p12 is a candidate gene for human obesity. PLoS Biol 2003; 1: E68.

  35. Meyre D, Boutin P, Tounian A, Deweirder M, Aout M, Jouret B, Heude B, Weill J, Tauber M, Tounian P, Froguel P. Is glutamate decarboxylase 2 (GAD2) a genetic link between low birth weight and subsequent development of obesity in children? J Clin Endocrinol Metab 2005; 90: 2384-90.

  36. Swarbrick MM, Waldenmaier B, Pennacchio LA, Lind DL, Cavazos MM, Geller F, Merriman R, Ustaszewska A, Malloy M, Scherag A, Hsueh WC, Rief W, Mauvais-Jarvis F, Pullinger CR, Kane JP, Dent R, McPherson R, Kwok PY, Hinney A, Hebebrand J, Vaisse C. Lack of support for the association between GAD2 polymorphisms and severe human obesity. PLoS Biol 2005; 3: e315.

  37. Groves CJ, Zeggini E, Walker M, Hitman GA, Levy JC, O’rahilly S, Hattersley AT, McCarthy MI, Wiltshire S. Significant Linkage of BMI to Chromosome 10p in the U.K. Population and Evaluation of GAD2 as a Positional Candidate. Diabetes 2006; 55: 1884-89.

  38. Sloan JL, Mager S. Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic aminoacid transporter B(0+).J Biol Chem 1999; 274: 23740-45.

  39. Halford JC, Blundell JE. Separate systems for serotonin and leptin in appetite control. Ann Med 2000; 32: 222-32.

  40. Blundell JE, Goodson S, Halford JC. Regulation of appetite: role of leptin in signalling systems for drive and satiety. Int J Obes Relat Metab Disord 2001; 25: S29-34.

  41. Suviolahti E, Oksanen LJ, Ohman M, Cantor RM, Ridderstrale M, Tuomi T, Kaprio J, Rissanen A, Mustajoki P, Jousilahti P, Vartiainen E, Silander K, Kilpikari R, Salomaa V, Groop L, Kontula K, Peltonen L, Pajukanta P. The SLC6A14 gene shows evidence of association with obesity. J Clin Invest 2003; 112: 1762-72.

  42. Durand E, Boutin P, Meyre D, Charles MA, Clement K, Dina C, Froguel P. Polymorphisms in the aminoacid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians. Diabetes 2004; 53: 2483-86.

  43. Herbert A, Gerry NP, McQueen MB, Heid IM, Pfeufer A, Illig T, Wichmann HE, Meitinger T, Hunter D, Hu FB, Colditz G, Hinney A, Hebebrand J, Koberwitz K, Zhu X, Cooper R, Ardlie K, Lyon H, Hirschhorn JN, Laird NM, Lenburg ME, Lange C, Christman MF. A common genetic variant is associated with adult and childhood obesity. Science 2006; 312: 279-83.

  44. Hall DH, Rahman T, Avery PJ, Keavney B. INSIG-2 promoter polymorphism and obesity related phenotypes: association study in 1428 members of 248 families. BMC Med Genet 2006; 7: 83.

  45. Dina C, Meyre D, Samson C, Tichet J, Marre M, Jouret B, Charles MA, Balkau B, Froguel P. Comment on “A common genetic variant is associated with adult and childhood obesity”. Science 2007; 315: 187b.

  46. Loos RJ, Barroso I, O’rahilly S, Wareham NJ. Comment on “A common genetic variant is associated with adult and childhood obesity”. Science 2007; 315: 187c.

  47. Rosskopf D, Bornhorst A, Rimmbach C, Schwahn C, Kayser A, Kruger A, Tessmann G, Geissler I, Kroemer HK, Volzke H. Comment on “A common genetic variant is associated with adult and childhood obesity”. Science 2007; 315: 187d.

  48. Gong Y, Lee JN, Brown MS, Goldstein JL, Ye J. Juxtamembranous aspartic acid in Insig-1 and Insig-2 is required for cholesterol homeostasis. Proc Natl Acad Sci USA 2006; 103: 6154-59.

  49. Horsthemke B, Buiting K. Imprinting defects on human chromosome 15. Cytogenet Genome Res 2006; 113: 292-99.

  50. Dong C, Li WD, Geller F, Lei L, Li D, Gorlova OY, Hebebrand J, Amos CI, Nicholls RD, Price RA. Possible genomic imprinting of three human obesity-related genetic loci. Am J Hum Genet 2005; 76: 427-37.

  51. Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, Stern MP, MacCluer JW, Blangero J. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997; 15: 273-76.

  52. Hsueh WC, Cole SA, Shuldiner AR, Beamer BA, Blangero J, Hixson JE, MacCluer JW, Mitchell BD. Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity. Diabetes Care 2001; 24: 672-7.

  53. Martin LJ, Cianflone K, Zakarian R, Nagrani G, Almasy L, Rainwater DL, Cole S, Hixson JE, MacCluer JW, Blangero J, Comuzzie AG. Bivariate linkage between acylation-stimulating protein and BMI and high-density lipoproteins. Obes Res 2004; 12: 669-78.

  54. Arya R, Duggirala R, Jenkinson CP, Almasy L, Blangero J, O’Connell P, Stern MP. Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican-Americans. Am J Hum Genet 2004; 74: 272-82.

  55. Canizales-Quinteros S, Aguilar-Salinas CA, Ortiz-López G, Rodríguez-Cruz M, Villarreal-Molina MT, Coral-Vázquez R, Huertas-Vázquez A, Hernández-Caballero A, López-Alarcón M, Brito-Zurita OR, Domínguez-Banda A, Martinez-Sánchez LA, Canto-de Cetina T, Vilchis-Dorantes G, Rosas-Vargas H, Granados-Silvestre MA, Medeiros-Domingo A, Menjivar M, Tusié-Luna MT. Association of PPARg2 Pro12Ala Variant with Larger Body Mass Index in Mestizo and Amerindian Populations of México. Hum Biol 2007; 79: 111-119.

  56. Villalobos-Comparan M, Aguilar-Salinas CA, Villarreal-Molina MT, Rodríguez-Cruz M, Flores-Dorantes MT, Jacobo-Albavera L, Huertas-Vazquez A, García-Ulloa C, Robles L, García-García E, Gómez-Pérez F, Yescas-Gómez P, Romero-Hidalgo S, Tusie-Luna MT, Canizales-Quinteros S. INSIG-2 polymorphism is associated with lower BMI and cholesterol/Apo B plasma levels in the Mexican population. Int J Obes (Enviado, 2007).

  57. Villarreal-Molina MT, Aguilar-Salinas CA, Rodríguez-Cruz M, Riaño D, Villalobos-Comparan M, Coral-Vázquez R, Menjivar M, Yescas-Gómez P, Könisberg-Fainstein M, Romero-Hidalgo S, Tusie-Luna MT, Canizales-Quinteros S and The Metabolic Study Group. The ABCA1 R230C Variant Affects HDL-cholesterol Levels and Body Mass Index in the Mexican Population: Association with Obesity and Obesity-Related Comorbidities. Diabetes 2007; 56: 1881-1887.




2020     |     www.medigraphic.com